Cargando…
Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with coronavirus disease 2019 (COVID-19) has raised great concerns. The effect of NSAIDs on the clinical status of COVID-19 remains in question. Therefore, we performed a post-hoc analysis from the ORCHID trial. Patients with COVI...
Autores principales: | Zhang, Jing, Sheng, Hongguang, Tang, Xiaoyi, Xia, Panpan, Li, Zhangwang, Xu, Minxuan, Ma, Jianyong, Shen, Yunfeng, Yu, Peng, Liu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618688/ https://www.ncbi.nlm.nih.gov/pubmed/36325468 http://dx.doi.org/10.3389/fcimb.2022.935280 |
Ejemplares similares
-
Liver Fibrosis Scores and Clinical Outcomes in Patients With COVID-19
por: Zhang, Jing, et al.
Publicado: (2022) -
Obesity and clinical outcomes in COVID-19 patients without comorbidities, a post-hoc analysis from ORCHID trial
por: Yu, Peng, et al.
Publicado: (2022) -
Evaluation of the Antibacterial and Anti-Inflammatory Effects of a Natural Products-Containing Toothpaste
por: Qi, Cai, et al.
Publicado: (2022) -
Anti-Inflammatory Metabolites in the Pathogenesis of Bacterial Infection
por: Urso, Andreacarola, et al.
Publicado: (2022) -
The Use of Adjunctive Steroids in Central Nervous Infections
por: Gundamraj, Shalini, et al.
Publicado: (2020)